Related references
Note: Only part of the references are listed.Sprouty2 enhances the tumorigenic potential of glioblastoma cells
Jong-Whi Park et al.
NEURO-ONCOLOGY (2018)
Human tripartite motif protein 52 is required for cell context-dependent proliferation
Stefan Benke et al.
Oncotarget (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition
Q. Zhang et al.
ONCOGENE (2016)
Lower Expression of SPRY4 Predicts a Poor Prognosis and Regulates Cell Proliferation in Colorectal Cancer
Xiaoling Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells
Angelina Doriguzzi et al.
ONCOLOGY LETTERS (2016)
Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases
Wanyu Zhang et al.
ONCOTARGET (2016)
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
Vanita Vanas et al.
PLOS ONE (2016)
Regulation of SPRY3 by X chromosome and PAR2-linked promoters in an autism susceptibility region (vol 24, pg 5126, 2015)
Zhenfei Ning et al.
HUMAN MOLECULAR GENETICS (2015)
The increased Sprouty4 expression in response to serum is transcriptionally controlled by Specific protein 1
Angelina Doriguzzi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer
Samar Masoumi-Moghaddam et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma
Alice M. Walsh et al.
MOLECULAR CANCER RESEARCH (2015)
The developing story of Sprouty and cancer
Samar Masoumi-Moghaddam et al.
CANCER AND METASTASIS REVIEWS (2014)
In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected
Rosana Maria Kral et al.
CELL BIOCHEMISTRY AND FUNCTION (2014)
Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines
Vanita Vanas et al.
TUMOR BIOLOGY (2014)
Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src
Yan Gong et al.
ANGIOGENESIS (2013)
Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells
Nadine Rathmanner et al.
FEBS LETTERS (2013)
Sprouty2 and-4 regulate axon outgrowth by hippocampal neurons
Barbara Hausott et al.
HIPPOCAMPUS (2012)
Differential expression of sprouty genes in hepatocellular carcinoma
Yongyut Sirivatanauksorn et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Differential actions of fibroblast growth factors on intracellular pathways and target gene expression in bovine ovarian granulosa cells
Zhongliang Jiang et al.
REPRODUCTION (2012)
Sprouty genes prevent excessive FGF signalling in multiple cell types throughout development of the cerebellum
Tian Yu et al.
DEVELOPMENT (2011)
Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas
H-J Kwak et al.
ONCOGENE (2011)
Sprouty 2 Is an Independent Prognostic Factor in Breast Cancer and May Be Useful in Stratifying Patients for Trastuzumab Therapy
Dana Faratian et al.
PLOS ONE (2011)
Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
Gerben Schaaf et al.
CANCER RESEARCH (2010)
Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities
Christoph-Erik Mayer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Characterisation of a new regulator of BDNF signalling, Sprouty3, involved in axonal morphogenesis in vivo
Niki Panagiotaki et al.
DEVELOPMENT (2010)
Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C
Simge Akbulut et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Sprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPAR(Y) in Non-Small Cell Lung Cancer
Meredith A. Tennis et al.
MOLECULAR CANCER RESEARCH (2010)
Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas
C. Holgren et al.
ONCOGENE (2010)
SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity
A. Barbachano et al.
ONCOGENE (2010)
Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth
Koji Taniguchi et al.
CANCER SCIENCE (2009)
Sprouty2 down-regulation promotes axon growth by adult sensory neurons
Barbara Hausott et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Modulation of endocrine pancreas development but not beta-cell carcinogenesis by Sprouty4
Fablenne Jaggi et al.
MOLECULAR CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms
Hedwig Sutterluety et al.
MOLECULAR CANCER RESEARCH (2007)
Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis
Alice T. Shaw et al.
GENES & DEVELOPMENT (2007)
Sprouty4, a suppressor of tumor cell motility, is downregulated by DNA methylation in human prostate cancer
JH Wang et al.
PROSTATE (2006)
The tumor suppressor PTEN is necessary for human sprouty 2-mediated inhibition of cell proliferation
F Edwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
CW Fong et al.
CANCER RESEARCH (2006)
The Ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer
TL Lo et al.
CANCER RESEARCH (2004)
The expression of sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer
B Kwabi-Addo et al.
CANCER RESEARCH (2004)
The receptor tyrosine kinase regulator sprouty1 is a target of the tumor suppressor WT1 and important for kidney development
I Gross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1
A Sasaki et al.
NATURE CELL BIOLOGY (2003)
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway
H Hanafusa et al.
NATURE CELL BIOLOGY (2002)
Neuroblastoma screening at one year of age
FH Schilling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Mammalian sprouty-1 and-2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells
MA Impagnatiello et al.
JOURNAL OF CELL BIOLOGY (2001)
Evidence for direct interaction between sprouty and Cbl
ESM Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)